YU56103A - Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata - Google Patents

Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata

Info

Publication number
YU56103A
YU56103A YU56103A YUP56103A YU56103A YU 56103 A YU56103 A YU 56103A YU 56103 A YU56103 A YU 56103A YU P56103 A YUP56103 A YU P56103A YU 56103 A YU56103 A YU 56103A
Authority
YU
Yugoslavia
Prior art keywords
hydrochloride dihydrate
improved process
ondansetron hydrochloride
preparing pure
pure ondansetron
Prior art date
Application number
YU56103A
Other languages
English (en)
Inventor
Ramy Lidor Hadas
Eliezer Bachar
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of YU56103A publication Critical patent/YU56103A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Predmetni pronalazak se odnosi na poboljšani postupak za pripremanje dimetilamino-metil-karbazolona i baze ondansetrona. Takodje je opisan i rekristalizacioni postupak za pripremanje čistog ondansetron hidrohlorid dihidrata čistoće od bar 99,0%.[An improved method for preparing dimethylamino-methyl-carbazolone and ondansetron base. A recrystallization process for preparing pure ondansetron hydrochloride dihydrate with a purity of at least 99.0% is also disclosed.
YU56103A 2001-01-11 2002-01-11 Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata YU56103A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26105201P 2001-01-11 2001-01-11

Publications (1)

Publication Number Publication Date
YU56103A true YU56103A (sh) 2006-05-25

Family

ID=22991757

Family Applications (1)

Application Number Title Priority Date Filing Date
YU56103A YU56103A (sh) 2001-01-11 2002-01-11 Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata

Country Status (21)

Country Link
EP (1) EP1355881A4 (sh)
JP (1) JP2004526692A (sh)
KR (3) KR20070054749A (sh)
CN (2) CN1496350A (sh)
AU (1) AU2002236753B2 (sh)
CA (1) CA2433720A1 (sh)
CZ (1) CZ20032090A3 (sh)
DE (1) DE02703115T1 (sh)
ES (1) ES2219201T1 (sh)
HR (1) HRP20030631A2 (sh)
HU (1) HUP0400767A2 (sh)
IL (1) IL156835A0 (sh)
IS (1) IS6869A (sh)
MX (1) MXPA03006215A (sh)
NO (1) NO20033147L (sh)
PL (1) PL368837A1 (sh)
SK (1) SK9892003A3 (sh)
TR (1) TR200401460T3 (sh)
WO (1) WO2002055492A2 (sh)
YU (1) YU56103A (sh)
ZA (1) ZA200305338B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040104654A (ko) 2002-04-29 2004-12-10 비오갈 기오기스제르갸르 알티. 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카르바졸-4-온의 제조 방법
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
GB2398071B (en) * 2003-01-24 2006-06-07 Synthon Bv Process for making ondansetron and intermediate thereof
US7696356B2 (en) 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
WO2006046253A1 (en) * 2004-10-26 2006-05-04 Ipca Laboratories Limited A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
MXPA03003761A (es) * 2000-10-30 2003-07-28 Teva Pharma Formas de cristales y solvatos de clorhidrato de ondansetron y procesos para su preparacion.

Also Published As

Publication number Publication date
WO2002055492A3 (en) 2003-02-13
JP2004526692A (ja) 2004-09-02
CA2433720A1 (en) 2002-07-18
EP1355881A4 (en) 2004-03-31
NO20033147D0 (no) 2003-07-09
PL368837A1 (en) 2005-04-04
DE02703115T1 (de) 2004-10-21
SK9892003A3 (en) 2004-05-04
HRP20030631A2 (en) 2005-06-30
CZ20032090A3 (cs) 2004-08-18
ES2219201T1 (es) 2004-12-01
CN101045704A (zh) 2007-10-03
KR20060113792A (ko) 2006-11-02
WO2002055492A2 (en) 2002-07-18
NO20033147L (no) 2003-09-02
HUP0400767A2 (hu) 2004-07-28
KR20070054749A (ko) 2007-05-29
MXPA03006215A (es) 2005-02-17
CN1496350A (zh) 2004-05-12
AU2002236753B2 (en) 2007-06-28
ZA200305338B (en) 2004-07-12
IL156835A0 (en) 2004-02-08
EP1355881A2 (en) 2003-10-29
IS6869A (is) 2003-07-08
TR200401460T3 (sh) 2004-08-23
KR20030068583A (ko) 2003-08-21

Similar Documents

Publication Publication Date Title
MX338829B (es) Metodo para preparar 3-halo-4,5-dihidro-1h-pirazoles.
HU0101336D0 (en) Process for the preparation of perindopril and their pharmaceutically acceptable salts
HK1069395A1 (en) Phthalazinone derivatives 2,3
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
AU2003293585A8 (en) Intermediate cefdinir salts
NZ509401A (en) Process for the preparation of quinoline derivative using the intermediate 2-cyclopropyl-3-(3-cyano-prop-2-ene)-4-(4-fluorophenyl)-quinoline
MXPA03004426A (es) Proceso quimico y nuevos intermediarios.
YU56103A (sh) Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata
BG104243A (en) Method for the synthesis of quinoline derivatives
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
HK1074833A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2003240634A8 (en) Method for producing bicalutamide
MXPA03010943A (es) Proceso para preparar un ligando de ppar de tiazol y polimorfos del mismo.
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
RS80604A (en) Purified lasoxifene and a method for purification of racemic lasofoxifene by recrystallization
HU0201262D0 (sh)
HK1044531A1 (en) Process for producing aliphatic tricarbonitriles
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
PL373083A1 (en) A process for the preparation of benazepril hydrochloride
GEP20094740B (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
IL146257A0 (en) Method of producing methoxyimido acetic amide
HUP0203547A3 (en) Ondasetron hydrochlorid dihydrate of high purity and process for its producing
GB0116094D0 (en) Vacuum regulation of process conditions
GB0115808D0 (en) Vacuum regulation of process conditions